| Literature DB >> 32007573 |
K Gomathi1, N Akshaya1, N Srinaath1, A Moorthi2, N Selvamurugan3.
Abstract
Osteogenesis is the process of new bone formation where transcription factors play an important role in controlling cell proliferation and differentiation. Runt-related transcription factor 2 (Runx2), a key transcription factor, regulates the differentiation of mesenchymal stem cells into osteoblasts, which further mature into osteocytes. Runx2 acts as a modulator such that it can either stimulate or inhibit the osteoblast differentiation. A defect/alteration in the expression/activity of this gene may lead to skeletal dysplasia. Runx2 thus serves as the best therapeutic model gene for studying bone and bone-related diseases. In this review, we briefly outline the regulation of Runx2 and its activity at the post-translational levels by the virtue of phosphorylation, acetylation, and ubiquitination in controlling the bone homeostasis.Entities:
Keywords: Acetylation; Osteoblast; Phosphorylation; Runx2; SUMOylation; Ubiquitination
Mesh:
Substances:
Year: 2020 PMID: 32007573 DOI: 10.1016/j.lfs.2020.117389
Source DB: PubMed Journal: Life Sci ISSN: 0024-3205 Impact factor: 5.037